Evidence map›Paper›PMID 41936669›Full record

ArticleHeart and vessels2026

Association between resting heart rate and clinical outcomes in heart failure with preserved ejection fraction: age stratified insights from the KUNIUMI Registry.

Tomohiro Matsuura, Hidekazu Tanaka, Wataru Fujimoto, Haruna Yokota, Koji Kuroda, Soichiro Yamashita, Junichi Imanishi, Masamichi Iwasaki, Takafumi Todoroki, Masanori Okuda and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tomohiro MatsuuraDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Hidekazu TanakaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. tanakah@med.kobe-u.ac.jp.ORCID http://orcid.org/0000-0002-1642-7039
Wataru FujimotoDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Haruna YokotaDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Koji KurodaDepartment of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
Soichiro YamashitaDepartment of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
Junichi ImanishiDepartment of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
Masamichi IwasakiDepartment of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
Takafumi TodorokiDepartment of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
Masanori OkudaDepartment of Cardiology, Hyogo Prefectural Awaji Medical Center, Sumoto, Japan.
Akihide KonishiClinical & Translational Research Center, Kobe University Hospital, Kobe, Japan.
Masakazu ShinoharaDivision of Epidemiology, Kobe University Graduate School of Medicine, Kobe, Japan.
Manabu NagaoDivision of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Ryuji TohDivision of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Kunihiro NishimuraDepartment of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hiromasa OtakeDivision of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

Funding

Osaka Gas Group Welfare Foundation N/A
6 · The paper itself

Abstract

Resting heart rate (HR) is a modifiable prognostic marker in heart failure (HF) with reduced ejection fraction, but its relevance in HF with preserved ejection fraction (HFpEF), especially among the very elderly, remains unclear. We aimed to evaluate the prognostic impact of elevated resting HR in HFpEF patients aged 80 years or older and compare it with those younger than 80 years. We prospectively studied 1,109 HFpEF patients from a total of 1,646 consecutive HF patients in the KUNIUMI Registry chronic cohort. Elevated HR was defined as resting HR of 70 beats per minute or more. The primary endpoint was a composite of cardiovascular death and HF hospitalization over a mean follow up of 1.77 ± 0.53 years. Among HFpEF patients in sinus rhythm (SR) aged below 80 years, HR of 70 beats per minute or more was significantly associated with worse cardiovascular outcomes (log rank P < 0.01). However, this association was attenuated in those aged 80 years or older in SR (log rank P = 0.11), and in patients with atrial fibrillation (AF), regardless of age. Elevated HR was independently associated with adverse outcomes in patients aged below 80 years in SR but not in those aged 80 years or older in SR. In conclusion, elevated resting HR is associated with adverse cardiovascular outcomes in HFpEF patients aged below 80 years in SR, but not in those aged 80 years or older or in those with AF. Age and rhythm specific approaches may be warranted in HFpEF management.

Indexed as

agingheart failure with preserved ejection fractionheart rate

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.